This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Indium
- DrugBank Accession Number
- DB11659
- Background
Indium has been used in trials studying the basic science of Clear Cell Renal Cell Carcinoma.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for Indium (DB11659)
- Weight
- Average: 114.818
Monoisotopic: 114.90387878 - Chemical Formula
- In
- Synonyms
- indio
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Product Ingredients
Ingredient UNII CAS InChI Key Indium Acetate BNM20F6I0P 25114-58-3 VBXWCGWXDOBUQZ-UHFFFAOYSA-K Indium Chloride 31JB8MKF8Z 10025-82-8 PSCMQHVBLHHWTO-UHFFFAOYSA-K Indium Citrate P7RCN32R8Q 4194-69-8 VSEUCCPAJZHJSX-UHFFFAOYSA-K Indium Nitrate WOP84073FA 13770-61-1 LKRFCKCBYVZXTC-UHFFFAOYSA-N Indium Sulfate 514CE39CG4 13464-82-9 XGCKLPDYTQRDTR-UHFFFAOYSA-H
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as homogeneous post-transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a post-transition metal atom.
- Kingdom
- Inorganic compounds
- Super Class
- Homogeneous metal compounds
- Class
- Homogeneous post-transition metal compounds
- Sub Class
- Not Available
- Direct Parent
- Homogeneous post-transition metal compounds
- Alternative Parents
- Not Available
- Substituents
- Homogeneous post-transition metal
- Molecular Framework
- Not Available
- External Descriptors
- boron group element atom (CHEBI:30430)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 045A6V3VFX
- CAS number
- 7440-74-6
- InChI Key
- APFVFJFRJDLVQX-UHFFFAOYSA-N
- InChI
- InChI=1S/In
- IUPAC Name
- indigane
- SMILES
- [In]
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Basic Science Clear Cell Renal Cell Carcinoma 1 somestatus stop reason just information to hide Not Available Completed Diagnostic Sarcoidosis 1 somestatus stop reason just information to hide 2 Completed Treatment Lymphoma 1 somestatus stop reason just information to hide 2 Terminated Treatment High Grade Glioma: Glioblastoma (GBM) 1 somestatus stop reason just information to hide 2 Terminated Treatment Lymphoma 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 0 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at October 20, 2016 20:38 / Updated at June 12, 2020 16:53